Hologic, Inc. (NASDAQ: HOLX) had its price target raised by analysts at Argus from $89.00 to $95.00. They now have a "buy" rating on the stock.
$2.75+ Epigenetic Markets - Global Industry Size, Share, Trends, Opportunity, and Forecasts, 2019-2023 & 2024-2029F [Yahoo! Finance]
A Dive into Hologic (HOLX) International Revenue Trends and Forecasts [Yahoo! Finance]
Hologic, Inc. (NASDAQ: HOLX) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Hologic, Inc. (NASDAQ: HOLX) had its price target raised by analysts at JPMorgan Chase & Co. from $85.00 to $91.00. They now have an "overweight" rating on the stock.